Unknown

Dataset Information

0

Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?


ABSTRACT: It is increasingly recognized that gastric cancer is a heterogeneous disease which may be divided into subgroups based on histological, anatomical, epidemiological and molecular classifications. Distinct molecular drivers and tumor biology, and thus different treatment targets and predictive biomarkers, may be implicated in each subtype. However, there is little evidence in the literature regarding the correlation among these different classifications, and particularly the molecular aberrations present in each subtype. In this review, we approach advanced gastric cancer (AGC) by presenting aberrant molecular pathways and their potential therapeutic targets in gastric cancer according to histological and anatomical classification, dividing gastric cancer into proximal nondiffuse, distal nondiffuse and diffuse disease. Several pathways are involved predominantly, although not exclusively, in different subtypes. This may help to explain the disappointing results of many published AGC trials in which study populations were heterogeneous regardless of clinicopathological characteristics of the primary tumor. Histological and anatomical classification may provide insights into tumor biology and facilitate selection of an enriched patient population for targeted agents in future studies and in the clinic. However, some molecular pathways implicated in gastric cancer have not been studied in correlation with histological or anatomical subtypes. Further studies are necessary to confirm the suggestion that such classification may predict tumor biology and facilitate selection of an enriched patient population for targeted agents in future studies and in the clinic.

SUBMITTER: Wong H 

PROVIDER: S-EPMC3539290 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Wong Hilda H   Yau Thomas T  

Therapeutic advances in gastroenterology 20130101 1


It is increasingly recognized that gastric cancer is a heterogeneous disease which may be divided into subgroups based on histological, anatomical, epidemiological and molecular classifications. Distinct molecular drivers and tumor biology, and thus different treatment targets and predictive biomarkers, may be implicated in each subtype. However, there is little evidence in the literature regarding the correlation among these different classifications, and particularly the molecular aberrations  ...[more]

Similar Datasets

| S-EPMC3801309 | biostudies-literature
| S-EPMC7229784 | biostudies-literature
| S-EPMC6457914 | biostudies-literature
| S-EPMC3395896 | biostudies-other
| S-EPMC10178968 | biostudies-literature
| S-EPMC5881006 | biostudies-literature
| S-EPMC4716053 | biostudies-literature
| S-EPMC3777192 | biostudies-literature
| S-EPMC9570397 | biostudies-literature
| S-EPMC4653714 | biostudies-other